Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance

Simple item page
dc.contributor.authorChatzigeorgiou, Antonios
dc.contributor.authorSeijkens, Tom
dc.contributor.authorZarzycka, Barbara
dc.contributor.authorEngel, David
dc.contributor.authorPoggi, Marjorie
dc.contributor.authorvan den Berg, Susan
dc.contributor.authorvan den Berg, Sjoerd
dc.contributor.authorSoehnlein, Oliver
dc.contributor.authorWinkels, Holger
dc.contributor.authorBeckers, Linda
dc.contributor.authorSchulte, Klaus-Martin
dc.date.accessioned2015-12-08T22:38:03Z
dc.date.issued2014
dc.date.updated2015-12-08T10:05:27Z
dc.description.abstractThe immune system plays an instrumental role in obesity and insulin resistance. Here, we unravel the role of the costimulatory molecule CD40 and its signaling intermediates, TNF receptor-associated factors (TRAFs), in diet-induced obesity (DIO). Although
dc.identifier.issn0027-8424
dc.identifier.urihttp://hdl.handle.net/1885/35783
dc.publisherNational Academy of Sciences (USA)
dc.rightsAuthor/s retain copyrighten_AU
dc.sourcePNAS - Proceedings of the National Academy of Sciences of the United States of America
dc.titleBlocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
dc.typeJournal article
dcterms.accessRightsOpen Accessen_AU
local.bibliographicCitation.issue7
local.bibliographicCitation.lastpage2691
local.bibliographicCitation.startpage2686
local.contributor.affiliationChatzigeorgiou, Antonios, Department of Clinical Pathobiochemistry
local.contributor.affiliationSeijkens, Tom, Department of Medical Biochemistry, Subdivision of Experimental Vascular Biology, Academic Medical Center
local.contributor.affiliationZarzycka, Barbara, Department of Biochemistry
local.contributor.affiliationEngel, David, Department of Pathology
local.contributor.affiliationPoggi, Marjorie, Department of Pathology
local.contributor.affiliationvan den Berg, Susan, Department of Medical Biochemistry,Subdivision of Experimental Vascular Biology, Academic Medical Center
local.contributor.affiliationvan den Berg, Sjoerd, Department of Human Genetics
local.contributor.affiliationSoehnlein, Oliver, Department of Pathology, Academic Medical Center
local.contributor.affiliationWinkels, Holger, Institute for Cardiovascular Prevention
local.contributor.affiliationBeckers, Linda, Department of Medical Biochemistry, Subdivision of Experimental Vascular Biology, Academic Medical Center
local.contributor.affiliationSchulte, Klaus-Martin, College of Medicine, Biology and Environment, ANU
local.contributor.authoruidSchulte, Klaus-Martin, u5512280
local.description.notesImported from ARIES
local.identifier.absfor110323 - Surgery
local.identifier.ariespublicationu4425841xPUB128
local.identifier.citationvolume111
local.identifier.doi10.1073/pnas.1400419111/-/DCSupplemental
local.identifier.scopusID2-s2.0-84894377101
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_Chatzigeorgiou_Blocking_CD40-TRAF6_signaling_2014.pdf
Size:
1.82 MB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS